Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 2980INDUSTRY 1488NIH 119OTHER_GOV 63NETWORK 36FED 8UNKNOWN 4INDIV 3

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 92Breast 59Thoracic 34Head & Neck 18Lymphoid 16CNS 11Other hematologic neoplasm 7Gynecologic 7Dermatologic 5Tumor-Agnostic 4Genitourinary 4Sarcoma 3Other solid neoplasm 3Other neoplasm 2NET 1Myeloid 1Endocrine 1

Conditions

Neoplasms 3Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Pemetrexed 1Paclitaxel 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Tumor-Agnostic × Clear all
NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

ChineseAMS

Phase 1/2 Unknown
60 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell

NCT03412344 2018-01-26

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

ChineseAMS

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

NCT03039062 2017-03-30

Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy

ChineseAMS

Unknown
180 enrolled
Tumor-Agnostic

Neoplasms

NCT02024321 2013-12-31

TPN

ChineseAMS

Completed
86 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡